AR 231453

Known as: AR-231453, AR231453 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2018
012320072018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Triglycerides (TGs) are among the most efficacious stimulators of incretin secretion; however, the relative importance of FFA1 (G… (More)
Is this relevant?
2014
2014
BACKGROUND AND PURPOSE GPR119 is a Gαs-coupled 7TM receptor activated by endogenous lipids such as oleoylethanolamide (OEA) and… (More)
Is this relevant?
2011
2011
Disordered glucagon secretion contributes to the symptoms of diabetes, and reduced glucagon action is known to improve glucose… (More)
Is this relevant?
2011
2011
G protein-coupled receptor 119 (GPR119) was originally identified as a β-cell receptor. However, GPR119 activation also promotes… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
We herein outline the design of a new series of agonists of the pancreatic and GI-expressed orphan G-protein coupled receptor… (More)
Is this relevant?
2011
2011
OBJECTIVE G protein-coupled receptor 119 (GPR119) is predominantly expressed in β cells and intestinal L cells. AR231453 is a… (More)
Is this relevant?
2010
2010
G protein-coupled receptor 119 (GPR119) is largely restricted to pancreatic insulin-producing beta-cells and intestinal glucagon… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
We recently showed that activation of G protein-coupled receptor 119 (GPR119) (also termed glucose dependent insulinotropic… (More)
Is this relevant?
2008
2008
GPR119 is a rhodopsin-like GPCR expressed in pancreatic beta-cells and incretin releasing cells in the GI tract. As with… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Pancreatic beta-cell dysfunction is a hallmark event in the pathogenesis of type 2 diabetes. Injectable peptide agonists of the… (More)
Is this relevant?